IMUNON INC
IMNN · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $1.08
- Today’s Low
- $1.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.06
- Previous Close
- $1.07
- Volume
- 42.48K
- Market Cap
- $6M
- P/E Ratio
- --
- EPS
- $-4.41
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 997 LENOX DRIVE, LAWRENCEVILLE, NJ, UNITED STATES, 08648
- Country
- US
- Listing Date
- 1993-10-27
- Fiscal Year End
- December
- Shares Outstanding
- 4.2M
- CIK
- 0000749647
- Website
- imunon.com
Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious diseases. Leveraging its proprietary INFECT platform, Imunon aims to enhance immune response mechanisms, facilitating effective tumor eradication. With a diversified pipeline of therapeutics across multiple clinical stages and strategic collaborations that bolster its operational expertise, Imunon is strategically positioned to revolutionize immunotherapy, offering the potential to significantly enhance treatment outcomes for patients while shaping the future of the biopharmaceutical landscape.
Financial Metrics
Revenue
2026-06-30
--
2026-03-31
$0
2025-12-31
-$725.2K
2025-09-30
$0
Operating Expenses
2026-06-30
$2.79M
2026-03-31
$4.14M
2025-12-31
$4.26M
2025-09-30
$3.47M
Net Income
2026-06-30
-$2.81M
2026-03-31
-$4.24M
2025-12-31
-$4.22M
2025-09-30
-$3.42M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
582.29%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.54
2026-03-31
$-0.84
2025-12-31
$-1.30
2025-09-30
$-1.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.56M
2026-03-31
-$4.08M
2025-12-31
-$4.05M
2025-09-30
-$3.26M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -- | $0 | -$725.2K | $0 |
| Operating Expenses | $2.79M | $4.14M | $4.26M | $3.47M |
| Net Income | -$2.81M | -$4.24M | -$4.22M | -$3.42M |
| Net Profit Margin | -- | -- | 582.29% | -- |
| Earnings Per Share | $-0.54 | $-0.84 | $-1.30 | $-1.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.56M | -$4.08M | -$4.05M | -$3.26M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.